These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17509106)

  • 1. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
    Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G
    Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components.
    Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W
    Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
    Otrock ZK; Beydoun A; Barada WM; Masroujeh R; Hourani R; Bazarbachi A
    Haematologica; 2008 Mar; 93(3):e36-7. PubMed ID: 18310533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
    Hoyt R; Szer J; Grigg A
    Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical side effects during peripheral blood progenitor cell infusion.
    Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
    Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
    Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
    Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical toxicity at the infusion of cryopreserved and thawed peripheral blood stem cell grafts in children].
    Okamoto Y; Takaue Y; Yasutomo K; Saito S; Hirao A; Matsunaga K; Abe T; Shimizu T; Sato J; Watanabe T
    Rinsho Ketsueki; 1992 Mar; 33(3):317-21. PubMed ID: 1578635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade.
    Rowley SD; Feng Z; Yadock D; Holmberg L; Macleod B; Heimfeld S
    Cytotherapy; 1999; 1(6):439-46. PubMed ID: 20426544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.
    Windrum P; Morris TC; Drake MB; Niederwieser D; Ruutu T;
    Bone Marrow Transplant; 2005 Oct; 36(7):601-3. PubMed ID: 16044141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.
    Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø
    Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
    Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
    Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product.
    Cordoba R; Arrieta R; Kerguelen A; Hernandez-Navarro F
    Bone Marrow Transplant; 2007 Dec; 40(11):1063-7. PubMed ID: 17906706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
    Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
    Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
    Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity Associated With Dimethyl Sulfoxide Used in Allogeneic Stem Cell Transplantation.
    Ataseven E; Tüfekçi Ö; Yilmaz Ş; Güleryüz H; Ören H
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e297-e299. PubMed ID: 28121745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.
    Benekli M; Anderson B; Wentling D; Bernstein S; Czuczman M; McCarthy P
    Bone Marrow Transplant; 2000 Jun; 25(12):1299-301. PubMed ID: 10871736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.